DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Chen R, Zinzani PL, Fanale MA. et al.
Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic hodgkin lymphoma.
J Clin Oncol 2017;
35: 2125-2132
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.